Memorial Sloan Kettering Cancer Center
New York, 10065, United States
NCT Number: NCT00594724
The purpose of this study is to see how the brain re-learns to control the tongue in speaking and swallowing when either portions of the tongue have been removed, or when the tongue has been treated with radiation, in order to treat cancer. We hope the results of this study will help us to improve healing for patients who are being treated for cancer of the tongue.
When patients with cancer of the tongue are treated by removing parts of the tongue (surgery) or by destroying the cancer with radiation to the tongue, they have significant difficulty speaking and swallowing after such treatments. At this time, patients who have been treated for cancer of the tongue re-learn speaking and swallowing through exercises taught by a speech pathologist.
What is needed is information on how the brain re-learns to control speaking and swallowing so that we can help these patients re-learn faster after their treatments.
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
New York, 10065, United States
The purpose of this investigation is to determine cortical mechanisms of adaptation to surgical or radiation treatment to the tongue. This study will use a non-invasive imaging technique, Functional Magnetic Resonance Imaging (fMRI), to investigate cortical responses to partial glossectomy or radiation therapy for treatment of a tongue malignancy. Patients with Stage I-IV (AJCC) malignancies of the tongue who are treated with surgery and or radiation therapy will be imaged using fMRI pre-operatively and at approximately six months postoperatively.
Patterns of brain activity from the fMRI studies will be compared with matched healthy control subjects. The results of this investigation will provide needed information on both central and peripheral mechanisms of adaptation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for the tongue carcinoma patients:
Inclusion criteria
for the healthy subjects:
Exclusion criteria
Exclusion criteria
for the tongue carcinoma patients include the following:
Exclusion criteria
for the healthy subjects includes the all of the conditions listed for the tongue:
Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging
Time frame: 7 years
Time frame: 7 years
Time frame: 7 years
Time frame: conclusion of study
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02254278
Carcinoma, Carcinoma, Squamous Cell
Birmingham, Alabama, United States
View Trial DetailsNCT01175980
Head and Neck Neoplasms, Mouth Diseases
Duarte, California, United States
View Trial DetailsNCT01254617
Carcinoma, Carcinoma, Squamous Cell
Columbus, Ohio, United States
View Trial DetailsNCT01256385
Carcinoma, Carcinoma, Squamous Cell
Scottsdale, Arizona, United States
View Trial Details